The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition(s):Atypical Hemolytic Uremic Syndrome (aHUS)Last Updated:March 10, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Atypical Hemolytic Uremic Syndrome (aHUS)Last Updated:March 10, 2017Completed
Condition(s):End-Stage Renal Disease; Kidney Failure; Graft Reperfusion InjuryLast Updated:August 31, 2018Completed
Condition(s):Polycystic Ovary Syndrome (PCOS) WomenLast Updated:January 23, 2013Unknown status
Condition(s):Chronic HemolysisLast Updated:April 18, 2012Unknown status
Condition(s):Stage V Chronic Kidney DiseaseLast Updated:May 3, 2019Completed
Condition(s):Shiga-like Toxin-producing Escherichia ColiLast Updated:April 5, 2013Completed
Condition(s):Delayed Function of Renal TransplantLast Updated:May 6, 2019Terminated
Condition(s):Antibody Mediated RejectionLast Updated:October 3, 2017Terminated
Condition(s):Kidney; Complications, AllograftLast Updated:August 12, 2019Completed
Condition(s):Cold Agglutinin DiseaseLast Updated:July 19, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.